Status:
UNKNOWN
Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
Lead Sponsor:
Sichuan Provincial People's Hospital
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to examine clinical utility of 18F-FAPI-RGD PET/CT imaging in evaluating connective tissue disease-associated interstitial lung disease. Participants will under...
Detailed Description
Interstitial lung disease is an overarching term for a wide range of disorders characterized by inflammation and/ or fibrosis in the lungs. Interstitial lung disease associated connective tissue disea...
Eligibility Criteria
Inclusion
- Age 18 and above
- Patients who have been diagnosed with, or are clinically highly suspected of ILD
- Patients who have been diagnosed with, or are clinically highly suspected of CTD-ILD
Exclusion
- Pregnant or breastfeeding
- Patients with tumor, other respiratory diseases, and lung surgery
- Abnormal cardiopulmonary function or mental state, unable tolerate PET/CT
Key Trial Info
Start Date :
August 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06143540
Start Date
August 16 2023
End Date
July 1 2024
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610072